eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse eHealthMe       Feature support groups

From FDA reports: drug interactions between Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole for a Male patient aged 57

This is a personalized study for a 57 year old male patient. The study is created by eHealthMe based on reports of 23 people who take the same drugs and have drug interactionsfrom FDA.

On Sep, 1, 2014: 23 people who reported to have interactions when taking Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole are studied

Trend of Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole's drug interactions, side effects, and effectiveness reports (1696743)

Information of the patient in this study:

Age: 57

Gender: male

Drugs taking:
- Navelbine
- Cisplatin
- Tramadol Hydrochloride
- Methimazole

Drug interactions have: Condition Aggravated, Fatigue, Non Small Cell Lung Cancer Stage Iv, Oedema Peripheral

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 57 (±5):

InteractionNumber of reports
Condition Aggravated (worse condition)2 (50.00%)
Fatigue (feeling of tiredness)2 (50.00%)
Non Small Cell Lung Cancer Stage Iv (the cancer has spread to other organs of the body)2 (50.00%)
Oedema Peripheral (superficial swelling)2 (50.00%)

Most common interactions experienced by males aged 57 (±5) in the use of Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole:

InteractionNumber of reports
Dyspnoea Nos4
Hypotension (abnormally low blood pressure)4
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)4
Hypoxia (low oxygen conditions)4
Myocardial Infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)3
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)2
Electrocardiogram St Segment Abnormal2
Pneumonia Nos2
Respiratory Failure (exc Neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))2
Hypocapnia (level of carbon dioxide in the blood is lower than normal)2

Most common interactions experienced by males aged 57 (±5) in long term use of Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Condition Aggravated (worse condition)4 (17.39%)
Fatigue (feeling of tiredness)2 (8.70%)
Non Small Cell Lung Cancer Stage Iv (the cancer has spread to other organs of the body)2 (8.70%)
Oedema Peripheral (superficial swelling)2 (8.70%)

Most common interactions experienced by people in the use of Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole:

InteractionNumber of reports
Neutropenia (an abnormally low number of neutrophils)16
Thrombocytopenia (decrease of platelets in blood)10
Pyrexia (fever)9
Dyspnoea Nos8
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)6
Rash (redness)6
Pleural Effusion (water on the lungs)6
Pulmonary Embolism (blockage of the main artery of the lung)6
Hypoxia (low oxygen conditions)4
Hypotension (abnormally low blood pressure)4

Most common interactions experienced by people in long term use of Navelbine, Cisplatin, Tramadol Hydrochloride, Methimazole:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.